SOLIRIS® (Eculizumab) Treatment of Participants With COVID-19

NCT04355494 · clinicaltrials.gov ↗

NO_LONGER_AVAILABLE

Status

INDUSTRY

Sponsor class

Conditions

COVID-19
Pneumonia, Viral
Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS)

Interventions

BIOLOGICAL: eculizumab

Sponsor

Alexion Pharmaceuticals, Inc.